DKSC (Dakshidin) DeferredTaxAndRevenue: $0.00 Mil (As of Sep. 2023)


What is Dakshidin DeferredTaxAndRevenue?

Dakshidin DKSC +33.33% DeferredTaxAndRevenue is $0.00 Mil as of Sep. 2023.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Dakshidin's current deferred tax and revenue for the quarter that ended in Sep. 2023 was $0.00 Mil.

Dakshidin DeferredTaxAndRevenue Related Terms

Dakshidin DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Dakshidin's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin DeferredTaxAndRevenue Chart

Dakshidin Annual Data
Trend
DeferredTaxAndRevenue

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
DeferredTaxAndRevenue 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.00 Mil mean?
Dakshidin (DKSC) has a DeferredTaxAndRevenue of $0.00 Mil as of Sep. 2023. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Dakshidin.
Is Dakshidin's DeferredTaxAndRevenue too high?
Dakshidin's current DeferredTaxAndRevenue is $0.00 Mil.
How does Dakshidin's DeferredTaxAndRevenue compare to ECEZ and AFBG?
Dakshidin's DeferredTaxAndRevenue of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Dakshidin. Dakshidin's current DeferredTaxAndRevenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current DeferredTaxAndRevenue of $0.00 Mil. The current DeferredTaxAndRevenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Dakshidin (DKSC), the current DeferredTaxAndRevenue is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.